Case Reports

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Aflac Cancer and Blood Disorders Center, Children Healthcare of Atlanta, Atlanta, GA, USA;
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA
Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA
Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA;
Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA
Dept. of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, USA
Haematologica Early view Jul 30, 2020 https://doi.org/10.3324/haematol.2020.262006